丁苯肽联合通心络治疗急性期脑梗死临床分析

The butylbenzene peptide tongxinluo treatment of acute cerebral infarction a clinical analysis

目的对丁苯肽联合通心络治疗急性期脑梗死效果进行分析研究。方法随机选择我院2011年2月至2012年2月急性期脑梗死患者76名,分成A、B两组,A组33名患者为对照组,行通心络进行医治;B组43名患者为治疗组,行丁苯肽联合通心络进行医治。结果经治疗,B组患者头晕、昏阙、肢体麻木等症状恢复效果高于A组,患者病情恢复相对于A组较好,治疗有效率高于A组。结论丁苯肽联合通心络治疗急性期脑梗死疾病,效果较好,患者病症恢复较好,有效率较高。

Objective Butylbenzene peptide Tongxinluo treatment of acute cerebral infarction effects a- nalysis. Methods Random selection in our hospital in February 2011 to February 2012, 76 patients with acute cerebral infarction, divided into two groups （A, B） A group of 33 patients in the control group, OK Tongxinluo heal; B group of 43 patientstreatment group, OK butylbenzene peptide macaroni network for medical treatment. Results After treatment, B in patients with dizziness, faint Que, numbness and other symptoms of recovery is significantly, higher than group A, patient recovery compared to group A better treatment efficiency than in group A. Conclusion The butylbenzene peptide Tongxinluo treatment of acute cerebral infarction disease better, bet- ter recovery in patients with the disease, more efficient.